# EKTERLY
> **NDA219301** · New Drug Application · Sponsor: KALVISTA · Approved 2025-07-03
## Drug
- **FDA Application Number:** NDA219301
- **Application type:** New Drug Application
- **Brand name:** EKTERLY
- **Generic name:** SEBETRALSTAT
- **Active ingredients:** SEBETRALSTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** KALVISTA
- **Manufacturer:** KalVista Pharmaceuticals Ltd
- **First approval:** 2025-07-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219301)
---
*MORVS · CC0 1.0*